Data Provide Insights Into How COVID-19 Vaccination Prioritization May Affect Eligibility by Poverty Level and Race and Ethnicity
March 9, 2021
Access more data on this topic in the associated statistical brief.
- Data Provide Insights Into How COVID-19 Vaccination Prioritization May Effect Eligibility by Poverty Level and Race and Ethnicity.
- Clinicians Offer Insight Into Factors Hindering Statin Guideline Adherence.
- Data Collection Devices Popular With Consumers Might Help Control Some Chronic Conditions.
- Online Tool Compares Emergency Department Visit Rates for Suicidal Ideation and Attempts.
- Highlights From AHRQ’s Patient Safety Network.
- AHRQ in the Professional Literature.
Data Provide Insights Into How COVID-19 Vaccination Prioritization May Effect Eligibility by Poverty Level and Race and Ethnicity
An AHRQ analysis of three hypothetical COVID-19 vaccine distribution plans showed that different prioritization schemes may lead to different trajectories of eligibility across population subgroups. In their analysis of data from AHRQ’s Medical Expenditure Panel Survey, agency researchers found that distributing the vaccine by age would simplify the process but slow vaccine eligibility across poverty levels and across race and ethnicity for key population subgroups. An alternative approach that granted relatively high priority to most essential workers and adults age 65 and older would result in quicker vaccine eligibility among adults in higher-income families and White adults than among adults living in poverty or racial and ethnic minorities. In another scenario, prioritizing adults at increased risk of severe COVID-19 ahead of non-healthcare high-priority occupation groups would increase access to the vaccine among Black adults and adults living in poverty, but would delay eligibility of some workers who have increased risk of exposure and increased risk of transmission to others.
Clinicians Offer Insight Into Factors Hindering Statin Guideline Adherence
While updated cholesterol guidelines recommended that more people in the United States would benefit from taking statins, the new guidelines resulted in only a nearly 2 percent increase in the use of statins to prevent and treat cardiovascular disease, according to an AHRQ-funded study published in the Journal of the American Board of Family Medicine. Patients at the highest risk of cardiovascular disease did not increase their statin use any more than patients in lower risk categories. Twenty-four clinicians and practice leaders interviewed reported that multiple factors impacted whether patients who could benefit from statins were receiving them. Some patients may have been influenced to resist updated guidelines by advertisements and the experiences others had with statins. Clinicians also expressed frustration with frequent changes to guidelines. Study authors suggested future guidelines may best focus on high-risk patients most likely to benefit. Access the abstract.
Data Collection Devices Popular With Consumers Might Help Control Some Chronic Conditions
Wearable consumer devices and mobile apps that collect health data such as heart rate and blood pressure might help patients control coronary artery disease, heart failure and asthma, according to an AHRQ evidence review. Evidence also indicated the devices shortened cardiac arrhythmia detection time and improved blood pressure, but there was no direct evidence of the impact on health outcomes for these two conditions. These technologies are not effective for addressing obesity, and evidence was unclear for seven other chronic conditions. Researchers evaluated the use of 118 devices and 26 mobile apps for prevention or treatment of 11 chronic conditions. They looked for evidence on the devices’ impact on health outcomes such as mortality, quality of life and symptom improvement. While possible positive effects were found for coronary artery disease, heart failure and asthma, impacts were unclear on obesity, and evidence showed a lack of effect on weight. The other five conditions studied were chronic obstructive pulmonary disease, diabetes prevention, sleep apnea, stroke and Parkinson’s disease. Access the Technical Brief.
Online Tool Compares Emergency Department Visit Rates for Suicidal Ideation and Attempts
A new online data tool from AHRQ allows users to explore state- and age-specific rates of emergency department visits related to suicide ideation and suicide attempts. The tool is among several interactive data visualizations that support the agency’s ongoing efforts to make data readily available to researchers, policymakers and other stakeholders. Previous data visualizations allow users to explore data related to health insurance cost sharing, characteristics and costs of potentially preventable hospital stays, the impacts and causes of traumatic brain injuries and trends in opioid-related hospitalizations. The newest tool is based on a statistical brief from AHRQ’s Healthcare Cost and Utilization Project.
Highlights From AHRQ's Patient Safety Network
AHRQ’s Patient Safety Network (PSNet) highlights journal articles, books and tools related to patient safety. Articles featured this week include:
- Parent engagement in perinatal mortality reviews: an online survey of clinicians from six high-income countries.
- National and institutional trends in adverse events over time: a systematic review and meta-analysis of longitudinal retrospective patient record review studies.
- Avoiding a Med-Wreck: a structured medication reconciliation framework and standardized auditing tool utilized to optimize patient safety and reallocate hospital resources.
AHRQ in the Professional Literature
Parent perspectives on pediatric inpatient OpenNotes. Smith CA, Coller RJ, Dean SM, et al. AMIA Annu Symp Proc 2020 Mar 4;2019:812-9. Access the abstract on PubMed®.
Healthy People 2030 health literacy definition tells organizations: make information and services easy to find, understand, and use. Brach C, Harris LM. J Gen Intern Med 2021 Jan 22. [Epub ahead of print.] Access the abstract on PubMed®.
Examining urban and rural differences in how distance to care influences the initiation and completion of treatment among insured cervical cancer patients. Spees LP, Brewster WR, Varia MA, et al. Cancer Epidemiol Biomarkers Prev 2019 May;28(5):882-9. Epub 2019 Feb 7. Access the abstract on PubMed®.
Ensuring sustainability of needed antibiotics: aiming for the DART Board. Spellberg B, Nielsen TB, Gilbert DN, et al. Ann Intern Med 2019 Oct 15;171(8):580-2. Epub 2019 Oct 8. Access the abstract on PubMed®.
Receipt of social needs assistance and health center patient experience of care. Nguyen KH, Trivedi AN, Cole MB. Am J Prev Med 2021 Mar;60(3):e139-e47. Epub 2020 Dec 11. Access the abstract on PubMed®.
Association of breast cancer surgery with quality of life and psychosocial well-being in young breast cancer survivors. Rosenberg SM, Dominici LS, Gelber S, et al. JAMA Surg 2020 Nov;155(11):1035-42. Access the abstract on PubMed®.
Variations in surgical spending within hospital systems for complex cancer surgery. Diaz A, Chhabra KR, Dimick JB, et al. Cancer 2021 Feb 15;127(4):586-97. Epub 2020 Nov 3. Access the abstract on PubMed®.
Provider networks and health plan premium variation. Polsky D, Wu B. Health Serv Res 2021 Feb;56(1):16-24. Epub 2020 Aug 13. Access the abstract on PubMed®.